Hunan Zhaotai Yongren Medical Innovation Co. Ltd.
Hunan Zhaotai Yongren Medical Innovation Co. Ltd.
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I | Anti-cancer Cell Immunotherapy; T Cell and NK Cell | Recruiting | Phase 1 / Phase 2 | 2024-06-26 | NCT03882840 | |
| GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Simpson-Golabi-Behmel syndrome, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, squamous cell lung carcinoma | Recruiting | Phase 1 | 2024-06-25 | NCT03198546 | |
| GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers | Neoplasms by Site, Thoracic Neoplasms, cancer, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2024-06-25 | NCT03198052 |